基于治疗前超声的深度学习影像组学模型预测乳腺癌新辅助化疗病理反应
多中心回顾性研究纳入603例接受新辅助化疗的乳腺癌患者,利用治疗前超声图像训练四种深度卷积神经网络并构建整合临床病理变量的深度学习影像组学模型。整合模型在训练集和验证集预测病理反应的AUC分别为0.962和0.939,优于仅图像模型、临床模型及两位放射科医师的预测,且医师在模型辅助下预测效能显著提升。
要点
- 治疗前超声深度学习影像组学模型可预测乳腺癌新辅助化疗病理反应。
- 整合临床病理变量的模型AUC达0.962(训练集)和0.939(验证集)。
- 放射科医师在模型辅助下预测效能显著提升。
局限性
- 回顾性研究设计。
- 原文未报告其他明显局限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To investigate the predictive performance of the deep learning radiomics (DLR) model integrating pretreatment ultrasound imaging features and clinical characteristics for evaluating therapeutic response after neoadjuvant chemotherapy (NAC) in patients with breast cancer.
METHODS: A total of 603 patients who underwent NAC were retrospectively included between January 2018 and June 2021 from three different institutions. Four different deep convolutional neural networks (DCNNs) were trained by pretreatment ultrasound images using annotated training dataset (n = 420) and validated in a testing cohort (n = 183). Comparing the predictive performance of these models, the best one was selected for image-only model structure. Furthermore, the integrated DLR model was constructed based on the image-only model combined with independent clinical-pathologic variables. Areas under the curve (AUCs) of these models and two radiologists were compared by using the DeLong method.
RESULTS: As the optimal basic model, Resnet50 achieved an AUC and accuracy of 0.879 and 82.5% in the validation set. The integrated DLR model, yielding the highest classification performance in predicting response to NAC (AUC 0.962 and 0.939 in the training and validation cohort), outperformed the image-only model and the clinical model and also performed better than two radiologists' prediction (all p < 0.05). In addition, predictive efficacy of the radiologists was improved under the assistance of the DLR model significantly.
CONCLUSION: The pretreatment US-based DLR model could hold promise as a clinical guidance for predicting NAC response of patients with breast cancer, thereby providing benefit of timely treatment strategy adjustment to potential poor NAC responders.
KEY POINTS: • Multicenter retrospective study showed that deep learning radiomics (DLR) model based on pretreatment ultrasound image and clinical parameter achieved satisfactory prediction of tumor response to neoadjuvant chemotherapy (NAC) in breast cancer. • The integrated DLR model could become an effective tool to guide clinicians in identifying potential poor pathological responders before chemotherapy. • The predictive efficacy of the radiologists was improved under the assistance of the DLR model.
引用
- Yu, Miao, Li, et al. Pretreatment ultrasound-based deep learning radiomics model for the early prediction of pathologic response to neoadjuvant chemotherapy in breast cancer. Eur Radiol. 2023. PMID: 36976336. doi:10.1007/s00330-023-09555-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。